News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Still no role for targeting PI3K pathway in mCRPC – Arun Azad
Photo from Arun Azad/Twitter
Jun 24, 2023, 18:25

Still no role for targeting PI3K pathway in mCRPC – Arun Azad

Now online Clinical Cancer Research- Phase IB study ipatasertib plus ipatasertib in mCR prostate cancer post-NHA. No evidence of synergistic or additive antitumor activity. No clear signal of benefit in biomarker +ve populations either.

My take: Still no role for targeting PI3K pathway in mCRPC

 

Source: Arun Azad/Twitter

antitumor Arun Azad cancer Clinical Cancer Research ipatasertib OncoDaily Oncology
Special Coverage
Blog
Dec 14, 2024, 13:07
Total Health Oncology - Cancer Matters: December Edition
Blog
Dec 14, 2024, 13:04
Tedros Adhanom Ghebreyesus: Health For All means everyone can access the health services they need, without financial hardship
Blog
Dec 14, 2024, 13:01
Breast International Group - Elisa Agostinetto receives the SABCS24 “Early Investigator Award”
Blog
Dec 14, 2024, 09:59
Evan Goldberg: Funding all-star scientists pursuing game changing research to achieve victory over cancer
Blog
Dec 14, 2024, 09:56
Sami (Papacek) Mansfield: 5-Minute High-Intensity Interval Training for cancer survivors
Blog
Dec 14, 2024, 09:50
The Canadian Cancer Statistics: A 2024 special report on the economic impact of cancer in Canada
Blog
Dec 14, 2024, 09:33
Elizabeth Ugwoma Awo-Ejeh: Cervical Cancer: Preventable, Treatable, and Beatable
Blog
Dec 14, 2024, 07:42
Parents' experiences with tumor genomic sequencing in pediatric oncology
Blog
Dec 14, 2024, 07:35
Francisco J. Esteva: Evolving nature of HER2 biomarkers
Blog
Dec 14, 2024, 07:33
Advancing Treatment Strategies for Muscle-Invasive Bladder Cancer - Mediamedic
Blog
Dec 14, 2024, 07:31
Aaron Goodman: Is giving Daratumumab to asymptomatic patients better than waiting until they develop cancer?
Societies
Dec 14, 2024, 07:01
2025 ESMO AI and Digital Oncology Annual Congress